Renaissance Fusion is a company that created superconductors that make straightforward fusion electricity affordable and MRIs a commonplace form of medical examination. The company's high-temperature superconductors for plasma devices and medical imaging enable customers to make fusion electricity affordable by bringing fusion energy to the grid.
Thorizon has rapidly evolved from a spin-off of NRG (Dutch Nuclear Research Institute) into an ambitious deep-tech startup, with offices in Amsterdam and Lyon. The company views small modular nuclear reactors as an ideal, stable, and clean contributor to an energy system where wind and solar are the other important sources. The ambition is to develop a reactor based on molten salt that can be realized rapidly and smartly, is ’walk-away’ safe, and takes a first step towards circularity by using long-lived nuclear waste as a fuel source. Thorizon is working to further strengthen its financial position to be able to build a non-nuclear molten salt demonstrator in the short term and finalize the detailed design to start building a first-of-a-kind reactor by 2030: the Thorizon One. Thorizon partners with industry leaders like Orano, Tractebel and EDF to advance its design and is a laureate in the France 2030 program for advanced nuclear projects. For more information about Thorizon, you can visit www.thorizon.com
CimCure focuses on the design and development of a novel class of active cancer immunotherapies. CimCure develops cancer vaccines using its unique Immune-Boost-tailored conjugate vaccination technology. It allows doctors to treat cancer more effectively by suppressing tumor growth.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.